Global Aspirin Market Segments 2024, Forecast To 2033
5 Mar, 2024
The aspirin market demonstrated steady growth, increasing from $2.47 billion in 2023 to $2.59 billion in 2024, with a 4.9% CAGR. Pain management, cardiovascular health awareness, and anti-inflammatory properties contributed to historical growth. The market is projected to reach $3.2 billion in 2028, driven by rising chronic diseases, pharmaceutical innovations, and the growing popularity of self-care practices.
Global Aspirin Market Key Driver
The aspirin market is anticipated to grow with the increasing prevalence of arthritis. Arthritis, a medical condition causing joint pain and swelling, is prevalent among adults. Aspirin, a nonsteroidal anti-inflammatory drug, is commonly used to manage chronic pain associated with arthritis. The Centers for Disease Control and Prevention reports that nearly 58.5 million adults in the U.S. suffer from doctor-diagnosed arthritis, with an expected increase to 78.4 million by 2040. The rising prevalence of arthritis contributes to the growth of the aspirin market.
Get A Free Sample Of The Global Aspirin Market ReportGlobal Aspirin Market Segments
The aspirin market covered in this report is segmented –
1) By Product: Prescription, OTC
2) By Route Of Administration: Oral, Rectal, Parenteral
3) By Dosage Form: Tablets, Capsules, Injections, Suppositories
4) By Application: Cardiovascular Disease, Pain, Fever, O Inflammation, Other Applications
5) By End User: Hospitals, Clinics, Other End Users
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
Asia-Pacific was the largest region in the aspirin market in 2023. The regions covered in the aspirin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Aspirin Industry Players
Bayer AG; Allegiant Health; Par Pharmaceutical; Cardinal Health Inc.; Nanjing pharmaceutical factory Co. Ltd.; JQC (Huayin) Pharmaceutical Co. Ltd.; LNK International Inc.; Bal Pharma Limited; Trumac Healthcare; Perrigo Company PLC; Alta Laboratories Ltd.; Zhenjiang Gaopeng Pharmaceutical Co. Ltd.; J.M. Loveridge Ltd.; Mayne Pharma Group Limited; St. Joseph's Aspirin; Teva Pharmaceutical Industries Ltd; Boehringer Ingelheim International GmbH; Cadila Healthcare Ltd.; Cipla Ltd.; Dr. Reddy's Laboratories Ltd.; GlaxoSmithKline plc; Hetero Labs Ltd.; Jubilant Generics Ltd.; Lupin Ltd.; Merck & Co. Inc.; Mylan N.V.; Novartis AG; Pfizer Inc.; Sanofi S.A.; Sun Pharmaceutical Industries Ltd.
Get The Full Global Aspirin Market Report
AIOps Aspirin Market Overview
Aspirin is a non-steroidal anti-inflammatory drug used to treat fever and minor aches. The chemical name of aspirin is acetylsalicylic acid (ASA). It is used for treating conditions such as arthritis and to reduce the chance of problems such as heart attack and stroke.
Aspirin Global Market Report 2023 provides data on the global aspirin market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The aspirin market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.